Solutions for CAR-T Antibody Development

We provide integrated R&D service of CAR-T antibodies preclinical candidate (PCC) R&D service covers six major modules, including material preparation, antibody discovery, in vitro efficacy screening, antibody engineering, in vivo efficacy evaluation and quality analysis. The close connections and cooperation between various modules help customers to quickly complete the research and development of the antibody for CAR-T therapy.

Service Highlights

1. Fast antibody discovery

• l Various types of differentiated antibody libraries are available for high-quality, fast-speed, and cost-efficient PCC R&D.

2. Integrated R&D platforms

• l A series of featured technology platforms make the R&D of CAR-T antibodys simple and efficient. With closely connected modules and preparation, the integrated R&D platforms enable delivery of the PCC antibodies for CAR-T within 12 months.

3. Enriched R&D experience

• l We have developed several candidates for CAR-T and accumulated extensive R&D experience.